急性心肌梗死心律失常应用门冬氨酸钾镁治疗的效果研究
2016-11-16武雯涛王莉
武雯涛+王莉

【摘要】目的 探讨急性心肌梗死心律失常患者应用门冬氨酸钾镁治疗的效果。方法 选取我院2012年1月~2015年12月接诊的急性心肌梗死心律失常患者100例,随即将其分为对照组与研究组,各50例。对照组以常规疗法处理,研究组以门冬氨酸钾镁治疗。观察记录两组患者效果、心律失常发生情况,以及治疗前后血清钾、血清镁水平。结果 研究组总有效率96.00%显著高于对照组76.00%(P<0.05);研究组室性、室上性及传导阻滞发生率均明显低于对照组(P<0.05);两组治疗前血清钾、血清镁比较,差异无统计学意义(P>0.05)。但治疗后研究组显著高于对照组(P<0.05)。结论 门冬氨酸钾镁治疗急性心肌梗死心律失常有不错效果,安全性高,值得借鉴。
【关键词】门冬氨酸钾镁;急性心肌梗死;心律失常;效果
【中图分类号】R542.22;R541.7 【文献标识码】A 【文章编号】ISSN.2095-6681.2016.15.00.02
【Abstract】Objective To investigate the effects of potassium magnesium aspartate in the treatment of patients with acute myocardial infarction arrhythmias.Methods The method according to random numbers in our hospital from January 2012 to December 2015 admissions with acute myocardial infarction arrhythmias 100 patients divided into two groups,50 cases in each group,the control group treated with conventional therapy,the study group to the door potassium magnesium aspartate treatment.The clinical effects of two groups were observed and recorded,arrhythmia,as well as serum potassium,serum magnesium levels before and after treatment,and take statistical analysis.Results The total efficiency of 96.00%significantly higher than 76.00%(P<0.05);Study Group ventricular,and supraventricular conduction block occurred were significantly lower than the control group(P<0.05);two before treatment,serum potassium,there was no significant difference(P>0.05) serum magnesium,but the treatment after the study group was significantly higher(P<0.05).Conclusion potassium magnesium aspartate in treating acute myocardial infarction arrhythmias have a good effect,safe,worth learning from.
【Key words】Potassium Magnesium Aspartate;acute myocardial infarction;arrhythmias;effect
急性心肌梗死属于临床常见疾病,是冠脉急性及持续性缺血缺氧造成的心肌坏死疾病,临床多有持久与剧烈胸骨后疼痛表现[1],且以硝酸酯类药物或休息后病症无法完全缓解,甚至有血清心肌酶活性升高,以及心电图异常等,威胁患者生命安全。近几年临床相关研究[2]显示,镁离子可增强细胞高能磷酸物质,对钙内流起到抑制作用,达到保护心肌的效果,同时可对抗心肌缺血时钙过度负荷。为了进一步分析镁制剂在急性心肌梗死心律失常中的效果,我院针对接诊的急性心肌梗死心律失常患者100例采取门冬氨酸钾镁与常规治疗实施了对照,报道如下。
1 资料与方法
1.1 一般资料
选取我院2012年1月~2015年12月接诊的急性心肌梗死心律失常患者100例,纳入标准:临床资料完整;确诊符合急性心肌梗死及其心律失常诊断标准;签署知情同意书愿意配合本次研究;……
